Sarepta Therapeutics Announces First Quarter 2025 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Sarepta Therapeutics Announces First Quarter 2025 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Lowers Guidance

May 6, 2025 4:19 PM EDT

Sarepta Therapeutics (NASDAQ: SRPT) reported Q1 EPS of ($3.42), $5.38 worse than the analyst estimate of $1.96. Revenue for the quarter came in at $774.9 million versus the consensus estimate of $695.9 million.

GUIDANCE:

Sarepta Therapeutics sees FY2025 revenue of $2.3-2.6 billion, versus the consensus of $3.07... More